Advances and prospects in adoptive cell transfer therapy for ovarian cancer

about

Advances and prospects in adoptive cell transfer therapy for ovarian cancer

Item

http://www.wikidata.org/entity/Q36852332

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Advances and prospects in adoptive cell transfer therapy for ovarian cancer

@en

type

Item

label

Advances and prospects in adoptive cell transfer therapy for ovarian cancer

@en

prefLabel

Advances and prospects in adoptive cell transfer therapy for ovarian cancer

@en

P1476

Advances and prospects in adoptive cell transfer therapy for ovarian cancer

@en

P2093

Daniel J Powell

http://www.w3.org/2001/XMLSchema#string

Katarzyna Urbanska

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression in patients after transfer of genetically engineered lymphocytes

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor.

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes.

Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes.

Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels.

Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.

P304

473-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/IMT.15.21

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26065472

http://www.w3.org/2001/XMLSchema#string

P932

4851244

http://www.w3.org/2001/XMLSchema#string